Mediatum Austria welcomed industry experts for an evening of mulled wine and sweet chestnuts.
(Vienna / 10.12.2013) – The baroque courtyard of the old Viennese town hall created the perfect christmassy frame for Mediatum's annual exclusive mulled wine stall for business partners and friends on 3rd of December 2013. About 120 industry experts had animated discussions and enjoyed soups, sweet chestnuts, lebkuchen, mulled wine and punsch at a mild temperature just over zero degrees.
Andreas Perklitsch, managing director of Mediatum Österreich GmbH and René Groeneveld, CEO of Mediatum AG were both pleased about the increasing popularity of the annual event.
The now traditional evening, away from the daily business gives everyone the opportunity to chat informally and undisturbed and seems to gain popularity within the Life Science industry from year to year. Five years ago, we welcomed 20 guests, this year, over 120 business partners and friends followed our invitation.
Among the guests at the Mediatum "Advent im Hof" were for example: Andreas Bayerle (Managing Director - Jeder GmbH Dental Technology), Gerhard Braun (HR Director - Takeda Pharma GesmbH), Andrea Domenig (HR Manager - Daiichi Sankyo Austria GmbH), Hartmut Ehrlich (CEO), Erich Eibensteiner (Managing Director - Janssen-Cilag Pharma GmbH), Walter Erber (Commercial Director - AOP Orphan Pharmaceuticals AG), Michaela Fritz (Head of Health & Environment Department - AIT), Peter Halwachs (Managing Director - Life Science Austria Vienna), Andreas Hauer (CFO - Savira Pharmaceuticals GmbH), Karl Hübler (Managing Director - EUCODIS Bioscience GmbH), Susanne Jech (Consultant - BECN), Astrid Kaltenböck (Director Operations R&D - Baxter AG), Bernhard Küenburg (General Manager - Biomedica Medizinprodukte GmbH & Co KG), Claudia Lingner (Managing Director - Ludwig Boltzmann Gesellschaft), Jürgen Marchart (Managing Director - AVCO), Werner Mikschicek (HR Director - Octapharma Pharmazeutika Produktionsges.m.b.H.), Thomas Moser (Managing Director - Pontis Capital GmbH), Karsten Schlemm (Senior Vice President CEE - Merz Pharma Austria GmbH), Gerald Schrot (Managing Director - Biotest Austria GmbH), Birgit Schunck (Managing Director - Gilead Sciences GmbH), Joachim Seipelt (Manager Innovation and Technologie - AWS), Andreas Steiner (CFO - AOP Orphan Pharmaceuticals AG), Gerald Strohmaier (HR Director - Intercell Austria AG), Nikolaus Zacherl (Managing Director - IMG Institut für medizinische Genomforschung PlanungsGmbH).